Exzeo Group
Exzeo Group's revenue rose 62.0% to $217 million in fiscal 2025. Its operating margin was 48.9%, up from 28.4% a year earlier. Free cash flow was $97 million, up 112.2%. It paid out $1 million in dividends and buybacks, 2% of free cash flow. The diluted share count rose 3.5%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Income statement
From fiscal 2023 to 2025, earnings per share grew 156.9% a year and net income 96.1% a year, as new shares raised the share count by 5% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | 15 | 54 | 305 |
| Debt incl. finance leases | — | — | — |
| Net debt (negative means net cash) | — | — | — |
| Net debt to EBITDA | — | — | — |
| Debt to equity | — | — | — |
| Interest coverage | 1.5x | 10.9x | — |
| Current ratio | — | 1.2x | 3.9x |
| Quick ratio | — | 1.2x | 3.9x |
Cash flow
Projections
Project Exzeo Group's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, 5 insiders bought $2.1 million of Exzeo Group shares on the open market, and none sold any.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 27, 2026 | Paresh PatelChief Executive Officer, Director | Bought plan | 2,000 | $13.67 | $27,340 | Form 4 |
| May 26, 2026 | Paresh PatelChief Executive Officer, Director | Bought plan | 2,000 | $13.26 | $26,520 | Form 4 |
| May 22, 2026 | Paresh PatelChief Executive Officer, Director | Bought plan | 2,000 | $12.92 | $25,840 | Form 4 |
| May 21, 2026 | Paresh PatelChief Executive Officer, Director | Bought plan | 2,000 | $12.82 | $25,640 | Form 4 |
| May 20, 2026 | Paresh PatelChief Executive Officer, Director | Bought plan | 2,000 | $13.33 | $26,660 | Form 4 |
| May 19, 2026 | Paresh PatelChief Executive Officer, Director | Bought plan | 2,000 | $13.69 | $27,380 | Form 4 |
| May 18, 2026 | Paresh PatelChief Executive Officer, Director | Bought plan | 2,000 | $13.93 | $27,860 | Form 4 |
| May 15, 2026 | Paresh PatelChief Executive Officer, Director | Bought plan | 2,000 | $13.68 | $27,355 | Form 4 |
| May 14, 2026 | Paresh PatelChief Executive Officer, Director | Bought plan | 2,000 | $13.75 | $27,500 | Form 4 |
| May 13, 2026 | Paresh PatelChief Executive Officer, Director | Bought plan | 2,000 | $13.55 | $27,100 | Form 4 |
| May 12, 2026 | Paresh PatelChief Executive Officer, Director | Bought plan | 2,000 | $13.85 | $27,700 | Form 4 |
| May 11, 2026 | Paresh PatelChief Executive Officer, Director | Bought plan | 2,000 | $13.99 | $27,980 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY24 | FY25 |
|---|---|---|
| Piotroski F-score | — | — |
| Rule of 40 | 85.9% | 106.9% |
| Altman Z'' | 1.78 | 9.69 |
| Accruals ratio | — | −8.0% |
The nine F-score tests
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | — | Pass |
| Cash from operations is positive | Pass | Pass |
| Return on assets rose | — | — |
| Cash from operations exceeds net income | Pass | Pass |
| Debt fell relative to assets | — | — |
| Current ratio rose | — | Pass |
| Share count didn't rise | Fail | Fail |
| Gross margin rose | Pass | Pass |
| Revenue rose relative to assets | — | — |
| F-score | — | — |
Compare
Put Exzeo Group side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Exzeo Group | FY25 | 62.0% | 48.9% | 44.9% | — | — | — | |
| Upland Software | FY25 | −21.1% | 2.0% | 11.3% | 1.9% | 5.5x | 5 | Compare |
| i3 Verticals | FY25 | 11.5% | 1.8% | 1.8% | 0.4% | −2.1x | 5 | Compare |
| VTEX | FY25 | 6.1% | 7.5% | 13.4% | 39.9% | −9.0x | 6 | Compare |
| Definitive Healthcare | FY25 | −4.2% | −92.9% | 15.3% | −38.3% | — | 5 | Compare |
3 years of figures
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | 88 | 134 | 217 |
| Revenue growth | — | 51.6% | 62.0% |
| Gross profit | 17 | 53 | 131 |
| Research and development | 6 | 6 | 9 |
| Operating income | 3 | 38 | 106 |
| Net income | 22 | 45 | 83 |
| Diluted EPS (US$) | 0.15 | 0.44 | 0.99 |
| Diluted shares (millions) | 76 | 78 | 80 |
| Cash flow | |||
| Cash from operations | 10 | 49 | 100 |
| Capital expenditure | 3 | 3 | 3 |
| Free cash flow | 7 | 46 | 97 |
| Dividends paid | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 2 |
| Acquisitions | 0 | 0 | 0 |
| Stock-based compensation | 3 | 3 | 3 |
| Balance sheet at fiscal year end | |||
| Cash and short-term investments | 15 | 54 | 305 |
| Debt incl. finance leases | — | — | — |
| Total assets | — | 89 | 348 |
| Total liabilities | — | 74 | 94 |
| Shareholders' equity | −25 | 16 | 254 |
| Margins and ratios | |||
| Gross margin | 19.6% | 39.7% | 60.4% |
| Operating margin | 2.9% | 28.4% | 48.9% |
| Net margin | 24.3% | 33.8% | 38.1% |
| Free cash flow margin | 7.8% | 34.3% | 44.9% |
| Rule of 40 (growth + FCF margin) | — | 85.9% | 106.9% |
| Return on capital | — | — | — |
| Return on equity | — | — | 61.4% |
| Return on assets | — | — | 37.9% |
| Net debt to EBITDA | — | — | — |